T-lymphocyte cytokine production

T-lymphocyte cytokine production is a complex biological process involving the synthesis and release of signaling proteins by T-cells to coordinate the adaptive immune response (PubMed: 25403443). Upon activation via the T-cell receptor (TCR) and costimulatory molecules, T-lymphocytes produce a diverse array of cytokines, such as Interleukin-2 (IL-2) and Interferon-gamma (IFN-g), which regulate the proliferation and effector functions of various immune cells (StatPearls: NBK537184). While this process is essential for host defense against pathogens, its dysregulation is a primary driver of autoimmune diseases, chronic inflammatory conditions, and life-threatening cytokine storms (PubMed: 18242580). Pharmacological agents do not target 'cytokine production' as a single molecule; instead, they target specific enzymes or receptors within the signaling cascade, such as calcineurin or Janus kinases, to suppress the overall production of these inflammatory mediators (PubMed: 28209142). Consequently, this term represents a physiological outcome or a phenotypic drug effect rather than a discrete molecular therapeutic target.

Other names

T-cell cytokine productionT-cell cytokine secretionT-lymphocyte activation-induced cytokine synthesisCytokine production by T-cells

Modulation of T-lymphocyte cytokine production is typically achieved by inhibiting upstream signaling pathways, such as the calcineurin-NFAT pathway, the mTOR pathway, or the Janus kinase (JAK)-STAT pathway, thereby preventing the transcription and secretion of pro-inflammatory cytokines (PubMed: 11511525, StatPearls: NBK537184).